What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Re-Up: Senator Mark Warner
Luxury Bunkers for the End of the World
Why It’s So Hard to Live in California
Designing a Better Facebook
Cyberspace Didn’t Stay Free
Public Education, Facebook-Style
Unmasking The Russians Who Hacked The DNC
What Happened To WikiLeaks
Fake Meat Designed for Carnivores
Local News Brought to You by Big Tech
Uber and Lyft Drivers Strike
Livestreaming A Massacre
Your Social Media Photos Are Helping to Build the Surveillance State
How To Trust A VPN
Empathy at Scale
Can Palantir Be Used For Good?
Jeff Bezos’s Privacy Complexifier
The Court-Records Paywall Scam
Media Layoffs Are Trending
Juul Heist
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts